Article R613-25-4 of the French Intellectual Property Code
The arrangements for the identification of products manufactured under compulsory licence pursuant to Article 10-5 of Regulation (EC) No 816/2006 are established by a decision of the Director General of the National Agency for the Safety of Medicines and Health Products.